Dr Martens takes first step towards £1bn-plus IPO

By Sam Kerr
11 Jan 2021

Dr Martens, the manufacturer of boots and shoes, filed initial paperwork for a flotation on the London Stock Exchange on Monday. The deal could be larger than £1bn ($1.37bn), according to sources speaking to GlobalCapital.

Goldman Sachs and Morgan Stanley are global co-ordinators on the IPO. Bank of America, Barclays, HSBC and RBC Capital Markets are bookrunners.

The IPO will consist of a sale of secondary shares owned by IngreLux, an investment vehicle owned by Permira, a private ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial